que es retatrutide Retatrutide—A Game Changer in Obesity Pharmacotherapy How Long Does Retatrutide Take
Description
In 2023, a trial of 17,604 adults (SELECT) with obesity and without T2DM, followed for over three years, showed a 20 percent reduction in major adverse cardiovascular events
Common side effects associated with GLP-1 receptor agonists in published clinical literature include nausea, vomiting, diarrhea, constipation, and abdominal discomfort
This may present as redness, itching, or irritation at the injection site
First, the delivery method is problematic
The collected used needles are then disposed of at a medical waste collection site
